Modelling long-term outcomes for patients with systemic lupus erythematosus

Systemic Lupus Erythematosus

LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

Ann Rheum Dis

Morand EF, van Vollenhoven R, Furie RA, Kalunian KC, Manzi S, Abreu G, Tummala R, Duncan EA, Al-Mossawi H, Lindholm C

doi: 10.1016/j.ard.2025.01.016

Systemic Lupus Erythematosus

Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events and Safety Outcomes in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation

Arthritis Rheumatol

Ma KS, Lo JE, Kyttaris VC, Tsokos GC, Costenbader KH

doi: 10.1002/art.43037

Systemic Lupus Erythematosus

Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Semin Arthritis Rheum

González LA, Harvey GB, Quintana R, Pons-Estel GJ, Ugarte-Gil MF, Vásquez G, Catoggio LJ, García MA, Borba EF, Da Silva NA, Brenol JCT, Toledano MG, Massardo L, Neira O, Pascual-Ramos V, Amigo MC, Barile-Fabris LA, Torre IG, Alfaro-Lozano J, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Iglesias-Gamarra A, Alarcón GS, Pons-Estel BA

doi: 10.1016/j.semarthrit.2024.152568

Systemic Lupus Erythematosus

Association between discontinuity of care and patient trust in the usual rheumatologist among patients with systemic lupus erythematosus: a cross-sectional study

Arthritis Res Ther

Katayama Y, Miyawaki Y, Shidahara K, Nawachi S, Asano Y, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Oguro N, Yajima N, Ishikawa Y, Sakurai N, Hidekawa C, Yoshimi R, Ohno S, Ichikawa T, Kishida D, Shimojima Y, Sada KE, Wada J, Thom DH, Kurita N

doi: 10.1186/s13075-024-03428-0

Systemic Lupus Erythematosus

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN 💡)

Arthritis Care Res (Hoboken)

Sanchez-Rodriguez A, Meade-Aguilar JA, Yang JX, Figueroa-Parra G, Hanson AC, Langenfeld HE, Thanarajasingam U, Chamberlain AM, Greenlund KJ, Barbour KE, Crowson CS, Duarte-García A

doi: 10.1002/acr.25445

Systemic Lupus Erythematosus

Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus

Semin Arthritis Rheum

Choi MY, Guan H, Yoshida K, Paudel M, Kargere BA, Li D, Ellrodt J, Stevens E, Cai T, Weber BN, Everett BM, Costenbader KH

doi: 10.1016/j.semarthrit.2024.152468

Systemic Lupus Erythematosus

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

Rheumatology (Oxford)

Katechis S, Nikolopoulos D, Flouda S, Adamichou C, Chavatza K, Kapsala N, Katsimbri P, Bertsias G, Boumpas DT, Fanouriakis A

doi: 10.1093/rheumatology/keae278

Systemic Lupus Erythematosus

Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

Arthritis Res Ther

Su Z, Zhang C, Gao C, Li C, Li R, Zheng Z

doi: 10.1186/s13075-024-03389-4

Systemic Lupus Erythematosus

Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort

Semin Arthritis Rheum

Deffendall C, Green S, Suh A, Nikolova N, Walker K, Whitney R, Wheless L, Osmundson S, Barnado A

doi: 10.1016/j.semarthrit.2024.152603

Related content

LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events and Safety Outcomes in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation

Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Association between discontinuity of care and patient trust in the usual rheumatologist among patients with systemic lupus erythematosus: a cross-sectional study

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN 💡)

Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort